Pfizer and BioNTech’s Covid-19 vaccine candidate shows promising efficacy
The interim analysis showed that BNT162b2 vaccine candidate is over 90% effective in preventing Covid-19 in participants without evidence of prior SARS-CoV-2 infection. BioNTech co-founder and CEO Ugur … Continue reading Pfizer and BioNTech’s Covid-19 vaccine candidate shows promising efficacy
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed